Journal of the Neurological Sciences 2003: Vol 206-216 Index

21 Pages·2003·4.4 MB·English

NeJouurnarl oof tlhe ogical
D it Sciences
aS BAS
ELSEVIER
Journal of the Neurological Sciences 216 (2003) 193-205
www.elsevier.com/locate/jns
Cumulative Author Index, Volumes 206—216 (2003)
Abbas Helmy, A., see Elwan, O. (211) 15 Asano, A., see Inoue, N. (210) 105
Abdel Shafy, S.. see Elwan, O. (211) 15 Ashton-Prolla, P., see Gomes, I. (214) 21
Abdel-Naseer, M., see Elwan, O. (211) 15 Athanasas-Platsis, S.. Zhang, B., Hillyard, N.C.. Cavanagh, A.C.,
Abe, H., see Kohshi, K. (209) 115 Csurhes, P.A., Morton, H. and McCombe, P.A.
Abe, K., see Hanyu, H. (209) 25 Early pregnancy factor suppresses the infiltration of lymphocytes and
Abe, K., see Ilieva, H. (215) 57 macrophages in the spinal cord of rats during experimental autoimmune
Ahsan Moosa, N.V., see Sylaja, P.N. (215) 9 encephalomyelitis but has no effect on apoptosis (214) 27
Aiba, I., see Ito, Y. (209) 105 Au, W.L., Lim, T.C.C., Seow, D.C.C., Koh, P.L., Loh, N.K., Lim, M.S.F.,
Aizawa, H., see Itoh, T. (214) 7 Tan, I.K. and Yee, W.C.
Akatsu, H., see Horimoto, Y. (216) 105 Serial diffusion-weighted magnetic resonance imaging in adult-onset
Akyiiz, F., see Durmaz, R. (215) 87 citrullinaemia (209) 101
Albers, D.S., see Lorenzl, S. (207) 71
Alcazar, A., see Cid, C. (206) 91
Alekseev, V.P., see Green, A.J.E. (212) 69 Baggi, F., see Mantegazza, R. (212) 31
Aller, M.A., see Lopez, L. (212) 93 Baier, M., see Nguyen, L.T. (209) 93
Alousi, S.S., see Petrov, T. (209) 31 Bakshi, R., see Bermel, R.A. (208) 57
Alvarez-Cermeno, J.C., see Cid, C. (206) 91 Bakshi, R., see Horsfield, M.A. (216) 169
Alvord Jr, E.C., see Swanson, K.R. (216) | Balash, Y., see Schaafsma, J.D. (212) 47
Ambrosio, S., see Barrachina, M. (215) 105 Bamborschke, S.U., see Petereit, H.F. (206) 209
Anagnostouli, M., see Paraskevas, G.P. (215) 51 Bams, J.L., see Schaafsma, A. (210) 23
Ando, J., see Sakamaki, M. (209) 69 Bankl, H.C., see Rauschka, H. (208) 101
Andre, C., see de Freitas, G.R. (210) 31 Barba, R., see Arpa, A. (210) 77
Annunziata, P., Figura, N., Galli, R., Mugnaini, F. and Lenzi, C. Barkhof, F., see Lycklama a Nijeholt, G. (206) 173
Association of anti-GM1 antibodies but not of anti-cytomegalovirus, Barkho*, F., see Lazeron, R.H.C. (213) 29
Campylobacter jejuni and Helicobacter pylori \gG, with a poor Barnett, M.H., Williams, D.B., Day, S., Macaskill, P. and McLeod, J.G.
outcome in Guillain—Barre syndrome (213) 55 Progressive increase in incidence and prevalence of multiple sclerosis in
Antonelli, G., see Bellomi, F. (215) 3 Newcastle, Australia: a 35-year study (213) |
Antozzi, C., see Mantegazza, R. (212) 31 Barrachina, M., Dominguez, I., Ambrosio, S., Secades, J., Lozano, R. and
Aoki, Y., see Matsuyama, Z. (210) 91 Ferrer, I.
Appel, S.H., see Trail, M. (209) 79 Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats
Appenzeller, O., Minko, T., Pozharov, V., Bonfichi, M., Malcovati, L., and in 6-hydroxydopamine-treated SH-SYSY human neuroblastoma
Gamboa, J. and Bernardi, L. cells (215) 105
Gene expression in the Andes; relevance to neurology at sea level (207) Barron, K.D.
37 Microglia: history, cytology, and reactions (207) 98
Arahata, Y., see Ito, Y. (209) 105 Bartels, A.L., see Schaafsma, J.D. (212) 47
Araujo, Abelardo Q.-C., see Leite, A.C.C. (214) 49 Baumhackl, U., see Rauschka, H. (208) 101
Arai, H., see Ito, S. (216) 179 Beal, M.F., see Lorenzl, S. (207) 71
Arai, K., see Kato, N. (210) 57 Becker, J., see Gomes, I. (214) 21
Arakawa, K., Tomi, H., Tobimatsu, S. and Kira, J.-1. Beggs, A.H., see Bénnemann, C.G. (206) 71
Middle latency auditory-evoked potentials in myotonic dystrophy: Beghi, E., see Mantegazza, R. (212) 31
relation to the size of the CTG trinucleotide repeat and intelligent Bellomi, F., Scagnolari, C., Tomassini, V., Gasperini, C., Paolillo, A.,
quotient (207) 31 Pozzilli, C. and Antonelli, G.
Araki, T., see Kato, H. (208) 9 Fate of neutralizing and binding antibodies to IFN beta in MS patients
Araya, S.-i., see Wang, H.-Y. (216) 61 treated with IFN beta for 6 years (215) 3
Arenas, J., see Seijo-Martinez, M. (208) 87 Bendersky, M., Rugilo, C., Kochen, S., Schuster, G. and Sica, R.E.P.
Arias, J., see Lopez, L. (212) 93 Magnetic resonance imaging identifies cytoarchitectonic subtypes of the
Arias, J.L., see Lopez, L. (212) 93 normal human cerebral cortex (211) 75
Arima, M., see Santa, Y. (212) 79 Benedict, R.H.B., see Horsfield, M.A. (216) 169
Arimura, K., see Kiwaki, T. (206) 17 Ben-Sasson, S.A., see lrony-Tur-Sinai, M. (206) 49
Arimura, K., see Umehara, F. (215) 111 Bermel, R.A., Sharma, J., Tjoa, C.W., Puli, S.R. and Bakshi, R.
Arimura, Y., see Kiwaki, T. (206) 17 A semiautomated measure of whole-brain atrophy in multiple sclerosis
Arimura, Y., see Umehara, F. (215) !11 (208) 57
Arpa, A., del Ser, T., Goda, G., Barba, R. and Bornstein, B. Bernardi, L., see Appenzeller, O. (207) 37
Apolipoprotein E, angiotensin-converting enzyme and a-1-antichymo- Bernardi, M., see Zivadinov, R. (216) 113
trypsin genotypes are not associated with post-stroke dementia (210) 77 Bernasconi, P., see Mantegazza, R. (212) 31
doi:10.1016/S0022-510X(03)00322-8
194 Cumulative Author Index, Volumes 206-216 (2003)
Bernasconi, S., see Rizzardini, M. (207) 51 Cauraugh, J.H. and Kim, S.
Berry, I., see Clanet, M. (206) 139 Progress toward motor recovery with active neuromuscular stimulation:
Bersudsky, M., see Ifergane, G. (213) 11 muscle activation pattern evidence after a stroke (207) 25
Berzin, T., see Salloway, S. (206) 115 Cauraugh, J.H. and Kim, S.B.
Bezerra, M., see de Freitas, G.R. (210) 31 Chronic stroke motor recovery: duration of active neuromuscular
Bianco, C., see Puccioni-Sohler, M. (207) 87 stimulation (215) 13
Bildirici, K., see Durmaz, R. (215) 87 Cavanagh, A., see Harness, J. (216) 33
Bill, P., see Bryer, A. (216) 47 Cavanagh, A.C., see Zhang, B. (212) 37
Biller, J., see Mayer, T.O. (207) 5 Cavanagh, A.C., see Athanasas-Platsis, S. (214) 27
Biousse, V., see Thambisetty, M. (208) 93 Cazzato, G., see Zivadinov, R. (210) 73
Birbeck, G.L. and Kalichi, E.M.N. Cazzato, G., see Zivadinov, R. (216) 113
The functional status of people with epilepsy in rural sub-Saharan Cevoli, S., see Mochi, M. (213) 7
Africa (209) 65 Chai, A., see Tan, E.-K. (216) 163
Bjartmar, C., Wujek, J.R. and Trapp, B.D. Chan, W.Y., see Chiu, T.W. (216) 143
Axonal loss in the pathology of MS: consequences for understanding Chandran, V.R., see Tan, E.-K. (216) 163
the progressive phase of the disease (206) 165 Chang, C.-Y., see Lin, J.-J. (209) 87
Blesa, R., see Casademont, J. (206) 23 Chang, D.-C., see Lin, J.-J. (209) 87
Bochynska, A., see Lojkowska, W. (216) 119 Charlton, C.S., Ridding, M.C., Thompson, P.D. and Miles, T.S.
Bogousslavsky, J., see Kuntzer, T. (207) 77 Prolonged peripheral nerve stimulation induces persistent changes in
Bonfichi, M., see Appenzeller, O. (207) 37 excitability of human motor cortex (208) 79
B6nnemann, C.G., Thompson, T.G., van der Ven, P.F.M., Goebel, H.H., Cheema, S.S., see Pamphlett, R. (216) 95
Warlo, I., Vollmers, B., Reimann, J., Herms, J., Gautel, M., Takada, F., Chen, M., Valenzuela, R.M. and Dhib-Jalbut, S.
Beggs, A.H., Fiirst, D.O., Kunkel, L.M., Hanefeld, F. and Schréder, R. Glatiramer acetate-reactive T cells produce brain-derived neurotrophic
Filamin C accumulation is a strong but nonspecific immunohistochem- factor (215) 37
ical marker of core formation in muscle (206) 71 Cheng, Q., Wang, D.-S., Jiang, G.-X., Han, H., Zhang, Y., Wang, W.-Z. and
Booth, F.W., see Deschenes, M.R. (210) 5 Fredrikson, S.
Bornstein, B., see Arpa, A. (210) 77 Prospective study of clinical epidemiology of Guillain—Barré syndrome
Bozzao, A., see Tombini, M. (213) 83 in Harbin, China (215) 63
Brannagan III, T.H. and Zhou, Y. Chimelli, L., see Puccioni-Sohler, M. (207) 87
HIV-associated Guillain-Barré syndrome (208) 39 Chin, R.L., Sherman, W.H., Sander, H.W., Hays, A.P. and Latov, N.
Bratina, A., see Zivadinov, R. (210) 73 Etanercept (Enbrel®) therapy for chronic inflammatory demyelinating
Brenneis, C., see Kofler, M. (216) 67 polyneuropathy (210) 19
Brenner, T., see Irony-Tur-Sinai, M. (206) 49 Chinnery, P.F., Howel, D., Turnbull, D.M. and Johnson, M.A.
Bridge, C., see Swanson, K.R. (216) | Clinical progression of mitochondrial myopathy is associated with the
Briones, M.L., see Servera, E. (209) 111 random accumulation of cytochrome c oxidase negative skeletal muscle
Brok, H.P.M., see *t Hart, B.A. (212) 21 fibres (211) 63
Brown, C.M., Diitsch, M., Hecht, M.J., Neundérfer, B. and Hilz, M.J. Chirichigno, J.W., see Lorenzl, S. (207) 71
Assessment of cerebrovascular and cardiovascular responses to lower Chishiki, T., see Sakamaki, M. (209) 69
body negative pressure as a test of cerebral autoregulation Chiu, T.W., Poon, P.W.F., Chan, W.Y. and Yew, D.T.W.
(208) 71 Long-term changes of response in the inferior colliculus of senescence
Brown, C.M., see Hecht, M.J. (213) 47 accelerated mice after early sound exposure (216) 143
Brownscheidle, C., see Nguyen, L.T. (209) 93 Cho, K.H., see Lo, S.S. (214) 43
Briick, W., Kuhlmann, T. and Stadelmann, C. Chui, D.H., see Santa, Y. (212) 79
Remyelination in multiple sclerosis (206) 181 Chung, H., see Tan, E.-K. (216) 163
Brune, N., see Hoffmann, V. (211) 81 Chung, S.-W., see Kim, J.-S. (206) 31
Brusa, A., see Jones, S.J. (206) 193 Ciancio, M.R., see Patti, F. (211) 55
Bryant, D., see Bryer, A. (216) 47 Cid, C., Alvarez-Cermenio, J.C., Regidor, I., Salinas, M. and Alcazar, A.
Bryer, A., Krause, A., Bill, P., Davids, V., Bryant, D., Butler, J., Low concentrations of glutamate induce apoptosis in cultured neurons:
Heckmann, J., Ramesar, R. and Greenberg, J. Implications for amyotrophic lateral sclerosis (206) 91
The hereditary adult-onset ataxias in South Africa (216) 47 Cimadevilla, J.M., see Lopez, L. (212) 93
Butler, J., see Bryer, A. (216) 47 Claassen, J., Hirsch, L.J. and Mayer, S.A.
Treatment of status epilepticus: a survey of neurologists (211) 37
Clanet, M., Cassol, E., Manelfe, C. and Berry, I.
Cacopardo, M., see Patti, F. (211) 55 Clinical—MRI correlations in the secondary progressive phase of MS:
Campos, Y., see Seijo-Martinez, M. (208) 87 lessons from the treatment trials (206) 139
Cantoni, L., see Rizzardini, M. (207) 51 Codella, M., see Holtmannsp6tter, M. (206) 27
Capone, J., see Govoni, V. (216) 99 Confalonieri, P., see Mantegazza, R. (212) 31
Cardellach, F., see Casademont, J. (206) 23 Confavreux, C., see Vukusic, S. (206) 135
Casademont, J., Miro, O., Rodriguez-Santiago, B., Viedma, P., Blesa, R. and Confavreux, C., see Vukusic, S. (206) 153
and Cardellach, F. Connor, J.R.
Cholinesterase inhibitor rivastigmine enhance the mitochondrial Iron transport proteins in the diseased brain (207) 112
electron transport chain in lymphocytes of patients with Alzheimer’s Cook, N.M., see Jacobs, D.A. (213) 77
disease (206) 23 Cornelio, F., see Mantegazza, R. (212) 31
Casetta, I., see Govoni, V. (216) 99 Correia, S., see Salloway, S. (206) 115
Cassol, E., see Clanet, M. (206) 139 Cortelli, P., see Mochi, M. (213) 7
Castro del Rio, M., see Seijo-Martinez, M. (208) 87 Costello, F., see Kolb, S.J. (216) 11
Castro del Rio, M., see Seijo-Martinez, M. (209) 119 Crosby, A.H., see Wilkinson, P.A. (216) 43
Cumulative Author Index, Volumes 206—216 (2003)
Csurhes, P.A., see Athanasas-Platsis, S. (214) 27 Ertilav, K., see Durmaz, R. (215) 87
Cudkowicz, M.E., see Lorenzl, S. (207) 71 Esiri, M.M., see Kennedy, P.G.E. (215) 27
Curran, B.C., see Sakamaki, M. (209) 69
Fallon, J., see Salloway, S. (206) 115
Danielsen, E.R., see Jeppesen, T.D. (214) 17 Fan, Y.H., see Mok, V.C.T. (216) 55
Danilova, A.P., see Green, A.J.E. (212) 69 Fazekas, F., see Petereit, H.F. (206) 209
Das, B.K., see Kalita, J. (208) 109 Felber, A., see Kofler, M. (216) 67
Davids, V., see Bryer, A. (216) 47 Feng, G., see Qin, W. (210) 35
Day, S., see Barnett, M.H. (213) 1 Fernandez Hojas, R., see Seijo-Martinez, M. (208) 87
De Carvalho, M., Turkman, A. and Swash, M. Ferro, M.T., see Mantegazza, R. (212) 31
Motor responses evoked by transcranial magnetic stimulation and Ferracin, F., see Fluri, F. (207) 43
peripheral nerve stimulation in the ulnar innervation in amyotrophic Ferrer, I., see Barrachina, M. (215) 105
lateral sclerosis: the effect of upper and lower motor neuron lesion (210) Ferrera, L., see Marini, V. (212) 75
83 Fidzianska, A. and Hausmanowa-Petrusewicz, I.
De Freitas, G.R., André, C., Bezerra, M., Nunes, R.G. and Vincent, M. Architectural abnormalities in muscle nuclei. Ultrastructural differences
Persistence of isolated flow in the internal carotid artery in brain death between X-linked and autosomal dominant forms of EDMD (210) 47
(210) 31 Figura, N., see Annunziata, P. (213) 55
De Jong, B.M., see Schaafsma, A. (210) 23 Filippi, M.
De Simone, R., see Tombini, M. (213) 83 MRI-—clinical correlations in the primary progressive course of MS:
De Sonneville, L., see Lazeron, R.H.C. (213) 29 new insights into the disease pathophysiology from the application of
Del Ser, T., see Arpa, A. (210) 77 magnetization transfer, diffusion tensor, and functional MRI
Delisle, M.B., see Vidal, R. (207) 110 (206) 157
Dembinska-Kiec, A., see Slowik, A. (214) 11 Filippi, M., see Holtmannspétter, M. (206) 27
Dennis, K., see Halpern, C. (208) 31 Filippi, M., see Horsfield, M.A. (216) 169
Deschenes, M.R., Will, K.M., Booth, F.W. and Gordon, S.E. Filosto, M., see Mancuso, M. (209) 61
Unlike myofibers, neuromuscular junctions remain stable during Fletcher, N.A., see Doran, M. (216) 127
prolonged muscle unloading (210) 5 Floris, R., see Tombini, M. (213) 83
Dewey Jr., R.B., see Frohman, E.M. (210) 65 Fluri, F., Ferracin, F., Erne, B. and Steck, A.J.
Dharmasaroja, P. Microheterogeneity of anti-myelin-associated glycoprotein antibodies
Specificity of autoantibodies to epitopes of myelin proteins in multiple (207) 43
sclerosis (206) 7 Fontoira, E., see Seijo-Martinez, M. (209) 119
Dhib-Jalbut, S., see Chen, M. (215) 37 Fontoira, M., see Seijo-Martinez, M. (209) 119
DiMauro, S., see Mancuso, M. (209) 61 Fook-Chong, S.M.C., see Tan, E.-K. (216) 163
Doi, Y., see Morita, Y. (212) 7 Forghani, B., see Morita, Y. (212) 7
Dominguez, I., see Barrachina, M. (215) 105 Fredrikson, S., see Cheng, Q. (215) 63
Doran, M., du Plessis, D.G., Enevoldson, T.P., Fletcher, N.A., Ghadiali, E. Frohman, E.M., O’Suilleabhain, P., Dewey Jr. .R.B., Frohman, T.C. and
and Larner, A.J. Kramer, P.D.
Pathological heterogeneity of clinically diagnosed corticobasal degen- A new measure of dysconjugacy in INO: the first-pass amplitude (210)
eration (216) 127 65
Dorcaratto, A., see Marini, V. (212) 75 Frohman, T.C., see Frohman, E.M. (210) 65
Drulovic, J., see Markovic, M. (211) 67 Frusho, K., see Yoshizawa, T. (215) 45
Druschky, A., see Hilz, M.J. (216) 153 Fujimoto, S., see Hagiwara, N. (212) 99
Druschky, K., see Hilz, M.J. (216) 153 Fujimoto, S., see Irie, F. (215) 115
Du Plessis, D.G., see Doran, M. (216) 127 Fukazawa, T., see Houzen, H. (211) 49
Dujmovic, I., see Markovic, M. (211) 67 Fukuoka, T., see Umehara, F. (215) 111
Dunand, M., see Kuntzer, T. (207) 77 Fukutake, T., see Ito, S. (206) 39
Durmaz, R., Ertilav, K., Akyiiz, F., Kanbak, G., Bildirici, K. and Tel, E. Fukutake, T., see Komatsu, K.-i. (216) 17
Lazaroid U-74389G attenuates edema in rat brain subjected to post- Fukutani, Y., see Kobayashi, K. (208) 17
ischemic reperfusion injury (215) 87 Fung, K.-M., see Jacobs, D.A. (213) 77
Dusenbery, K.E., see Lo, S.S. (214) 43 Fiirst, D.O., see B6nnemann, C.G. (206) 71
Diitsch, M., see Brown, C.M. (208) 71 Furuya, H., see Osoegawa, M. (209) 5
Furuya, H., Yasuda, M., Terasawa, K.-j., Tanaka, K., Murai, H., Kira, J.-i.
and Ohyagi, Y.
Ehlers, J.A.C., see Gomes, I. (214) 21 A novel mutation (L250V) in the presenilin | gene in a Japanese
El Faiuomy, N., see Elwan, O. (211) 15 familial Alzheimer’s disease with myoclonus and generalized con-
Ellenbogen, J., see Kolb, S.J. (216) 11 vulsion (209) 75
Els, T., see Kassubek, J. (212) 85
Elwan, F., see Elwan, O. (211) 15
Elwan, O., Madkour, O., Elwan, F., Mostafa, M., Abbas Helmy, A., Gajdusek, D.C., see Green, A.J.E. (212) 69
Abdel-Naseer, M., Abdel Shafy, S. and El Faiuomy, N. Galetta, S.L., see Kolb, S.J. (216) 11
Brain aging in normal Egyptians: cognition, education, personality, Galli, R., see Annunziata, P. (213) 55
genetic and immunological study (211) 15 Gamboa, J., see Appenzeller, O. (207) 37
Endo, K., see Takashima, Y. (214) 37 Garcia-Rill, E., see Uc, E.Y. (212) 1
Enevoldson, T.P., see Doran, M. (216) 127 Garré, C., see Marini, V. (212) 75
Eriguchi, M., see Takashima, H. (207) 59 Gasperini, C., see Bellomi, F. (215) 3
Erne, B., see Fluri, F. (207) 43 Gautel, M., see B6nnemann, C.G. (206) 71
196 Cumulative Author Index, Volumes 206—216 (2003)
Gerwig, M., Kastrup, O., Meyer, B.-U. and Niehaus, L. Hanyu, H., Shimuzu, T., Tanaka, Y., Takasaki, M., Koizumi, K. and
Evaluation ofc ortical excitability by motor and phosphene thresholds in Abe, K.
transcranial magnetic stimulation (215) 75 Effect of age on regional cerebral blood flow patterns in Alzheimer’s
Ghadiali, E., see Doran, M. (216) 127 disease patients (209) 25
Ghetti, B., see Vidal, R. (207) 110 Harada, A., see Ochi, K. (208) 43
Giladi, N., see Schaafsma, J.D. (212) 47 Harness, J., Cavanagh, A., Morton, H. and McCombe, P.
Gilden, D.H., see Morita, Y. (212) 7 A protective effect of early pregnancy factor on experimental
Giovannoni, G., see Rejdak, K. (208) | autoimmune encephalomyelitis induced in Lewis rats by inoculation
Giugliani, R., see Gomes, I. (214) 21 with myelin basic protein (216) 33
Glass, D., see Salloway, S. (206) 115 Harris, Z.L.
Goda, G., see Arpa, A. (210) 77 Aceruloplasminemia (207) 108
Goebel, H.H., see B6nnemann, C.G. (206) 71 Hart, P.E., see Wilkinson, P.A. (216) 43
Goldberg, H.I., see Jacobs, D.A. (213) 7 Hartung, H.P., see Petereit, H.F. (206) 209
Goldfarb, L.G., see Green, A.J.E. (212) 69 Hartwich, J., see Slowik, A. (214) 11
Gomes, I., Nora, D.B., Becker, J., Ehlers, J.A.C., Schwartz, LV.D.. Hashimoto, K., see Itoh, T. (214) 7
Giugliani, R., Ashton-Prolla, P. and Jardim, L. Hattori, N., see Kobayashi, T. (207) 11
Nerve conduction studies, electromyography and sympathetic skin Hattori, T., see Ito, S. (206) 39
response in Fabry’s disease (214) 21 Hattori, T., see Ogawara, K. (210) 41
Gomez-Merino, E., see Servera, E. (209) 111 Hattori, T., see Kato, N. (210) 57
Goncalves, R.R., see Puccioni-Sohler, M. (207) 87 Hattori, T., see Komatsu, K.-i. (216) 17
Gonsette, R.E. Hattori, T., see Ito, S. (216) 179
Mitoxantrone in progressive multiple sclerosis: when and how to treat? Hausdorff, J.M., see Schaafsma, J.D. (212) 47
(206) 203 Hausmanowa-Petrusewicz, I., see Fidzianska, A. (210) 47
Gordon, S.E., see Deschenes, M.R. (210) 5 Hayasaka, K., see Numakura, C. (210) 61
Goto, K., see Tagawa, K. (211) 23 Hayashi, M., see Kobayashi, K. (208) 17
Gourie-Devi, M. and Nalini, A. Hayashi, M., see Matsuyama, Z. (210) 91
Madras motor neuron disease variant, clinical features of seven patients Hayashi, Y.K., see Tagawa, K. (211) 23
(209) 13 Hayflick, S.J.
Govoni, V., Granieri, E., Manconi, M., Capone, J. and Casetta, I. Pantothenate kinase-associated neurodegeneration (formerly Hallervor-
Is there a decrease in Guillain-Barré syndrome incidence after bovine den-—Spatz Syndrome) (207) 106
ganglioside withdrawal in Italy? A population-based study in the Local Hays, A.P., see Chin, R.L. (210) 19
Health District of Ferrara, Italy (216) 99 He, L., see Qin, W. (210) 35
Gran, B., see Li, J. (215) 95 Hecht, M.J., see Brown, C.M. (208) 71
Granieri, E., see Govoni, V. (216) 99 Hecht, M.J., Brown, C.M., Mittelhamm, F., Werner, D., Heuss, D.,
Green, A.J.E., Sivtseva, T.M., Danilova, A.P., Osakovsky, V.L., Neundérfer, B. and Hilz, M.-J.
Viadimirtsev, V.A., Zeidler, M., Knight, R.S., Platonov, F.A., Increased hypoxic blood pressure response in patients with amyotrophic
Shatunov, A., Alekseev, V.P., Krivoshapkin, V.G., Masters, C.L., lateral sclerosis (213) 47
Gajdusek, D.C. and Goldfarb, L.G. Heckmann, J., see Bryer, A. (216) 47
Viliuisk encephalomyelitis: intrathecal synthesis of oligoclonal IgG Hellwig, K., see Hoffmann, V. (211) 81
(212) 69 Herms, J., see B6nnemann, C.G. (206) 71
Greenberg, J., see Bryer, A. (216) 47 Herpers, M., see Kassubek, J. (212) 85
Grinfeld, E., see Kennedy, P.G.E. (215) 27 Heuss, D., see Hecht, M.J. (213) 47
Grossman, M., see Halpern, C. (208) 31 Higaki, M., see Ochi, K. (208) 43
Gur, T., see Salloway, S. (206) 115 Hilgenberg, S.L., see Lorenzl, S. (207) 71
Gurevich, T., see Schaafsma, J.D. (212) 47 Hillyard, N.C., see Zhang, B. (212) 37
Hillyard, N.C., see Athanasas-Platsis, S. (214) 27
Haaxma-Reiche, H., see Schaafsma, A. (210) 23 Hilz, M.J., see Brown, C.M. (208) 71
Hagiwara, H., see Sakamaki, M. (209) 69 Hilz, M.-J., see Hecht, M.J. (213) 47
Hagiwara, N., Toyoda, K., Fujimoto, S. and Okada, Y. Hilz, M.J., Platsch, G., Druschky, K., Pauli, E., Kuwert, T., Stefan, H.,
Extensive bihemispheric ischemia caused by acute occlusion of three Neund6rfer, B. and Druschky, A.
major arteries to the brain (212) 99 Outcome of epilepsy surgery correlates with sympathetic modulation
Hagiwara, N., see Irie, F. (215) 115 and neuroimaging of the heart (216) 153
Hahn, A.F., see Kuntzer, T. (207) 77 Hirata, K., see Odaka, M. (210) 99
Hall, W.A., see Lo, S.S. (214) 43 Hirata, K., see Odaka, M. (211) 93
Halpern, C., McMillan, C., Moore, P., Dennis, K. and Grossman, M. Hirono, N., see Ishii, K. (215) 71
Calculation impairment in neurodegenerative diseases Hirsch, L.J., see Claassen, J. (211) 37
(208) 31 Hoffmann, V., Schimrigk, S., Islamova, S., Hellwig, K., Lukas, C.,
Hamaue, N., see Ogata, A. (206) 79 Brune, N., Péhlau, D., Przuntek, H. and Miiller, T.
Hammen, , Stefan, H., Pauli, E., Schafer, I., Huk, W. and Tomandl, B. Efficacy and safety of repeated intrathecal triamcinolone
1H-MR spectroscopy: a promising method in distinguishing subgroups acetonide application in progressive multiple sclerosis patients
in temporal lobe epilepsy? (215) 21 (211) 81
Han, H., see Cheng, Q. (215) 63 Holtmannspotter, M., Inglese, M., Rovaris, M., Rocca, M.A., Codella, M.
Han, J., see Qin, W. (210) 35 and Filippi, M.
Han, S.-R., see Kim, J.-S. (206) 31 A diffusion tensor MRI study of basal ganglia from patients with
Hanefeld, F., see B6nnemann, C.G. (206) 71 ADEM (206) 27
Hansen, K., see Jeppesen, T.D. (214) 17 Hommes, O.R., see Petereit, H.F. (206) 209
Cumulative Author Index , Volumes 206—216 (2003)
Horimoto, Y., Matsumoto, M., Nakazawa, H., Yuasa, H., Morishita, M.., Inoue, T., see Irie, F. (215) 115
Akatsu, H., Ikari, H., Yamamoto, T. and Kosaka, K. Inuzuka, T., see Matsuyama, Z. (210) 91
Cognitive conditions of pathologically confirmed dementia with Lewy Irie, F., Fujimoto, S., Uda, K., Toyoda, K., Hagiwara, N., Inoue, T. and
bodies and Parkinson’s disease with dementia (216) 105 Okada, Y.
Horsfield, M.A., Rovaris, M., Rocca, M.A., Rossi, P., Benedict, R.H.B., Primary intraventricular hemorrhage from dural arteriovenous fistula
Filippi, M. and Bakshi, R. (215) 115
Whole-brain atrophy in multiple sclerosis measured by two segmenta- lrony-Tur-Sinai, M., Vlodavsky, I., Ben-Sasson, S.A., Pinto, F., Sicsic, C.
tion processes from various MRI sequences (216) 169 and Brenner, T.
Hou, J.-G. and Jankovic, J. A synthetic heparin-mimicking polyanionic compound inhibits central
Movement disorders in Friedreich’s ataxia (206) 59 nervous system inflammation (206) 49
Houzen, H., Niino, M., Kikuchi, S., Fukazawa, T., Nogoshi, S., Iseki, E., see Katsuse, O. (211) 29
Matsumoto, H. and Tashiro, K. Ishida, K., see Mitoma, H. (208) 51
The prevalence and clinical characteristics of MS in northern Japan Ishii, K., Mori, T., Hirono, N. and Mori, E.
(211) 49 Glucose metabolic dysfunction in subjects with a Clinical Dementia
Hovanesian, V., see Salloway, S. (206) 115 Rating of 0.5 (215) 71
Howel, D., see Chinnery, P.F. (211) 63 Iskra, T., see Slowik, A. (214) 11
Hozumi, I., see Matsuyama, Z. (210) 91 Islamova, S., see Hoffmann, V. (211) 81
Hughes, R.A.C. Ito, E., see Ito, Y. (209) 105
Interferon beta la for secondary progressive multiple sclerosis (206) Ito, K., see Ito, Y. (209) 105
199 Ito, S., Hattori, T., Fukutake, T. and Sugimoto, K.
Hui, A.C.F., see Mok, V.C.T. (216) 55 Is atopic dermatitis a risk factor for intervertebral disc degeneration? A
Huk, W., see Hammen, (215) 21 preliminary clinical and MRI study (206) 39
Hulette, C., see Salloway, S. (206) 115 Ito, S., Kuwabara, S., Sakakibara, R., Oki, T., Arai, H., Oda, S. and
Hattori, T.
Combined treatment with LDL-apheresis, chenodeoxycholic acid and
Ibayashi, S., see Kishikawa, K. (213) 19 HMG-CoA reductase inhibitor for cerebrotendinous xanthomatosis
Ichikizaki, K., see Inamasu, J. (209) 55 (216) 179
Ifergane, G., Bersudsky, M., Kachko, L. and Wirguin, I. Ito, Y., Kato, T., Suzuki, T., Yokokawa, Y., Aiba, I., Arahata, Y., Ito, E.,
Induction of conduction block by Campylobacter jejuni lipopolysac- Ito, K., Yasuda, T. and Sobue, G.
charides and focal neural insult (213) 11 Neuroradiologic and clinical abnormalities in dementia of diffuse
Igarashi, H., see Sakamaki, M. (209) 69 neurofibrillary tangles with calcification (Kosaka—Shibayama disease)
lida, M., see Kishikawa, K. (213) 19 (209) 105
Ikari, H., see Horimoto, Y. (216) 105 Itoh, K., see Kiwaki, T. (206) 17
Ikeda, J., see Ochi, K. (208) 43 Itoh, T., Aizawa, H., Hashimoto, K., Kimura, T., Katayama, T., Koyama, S.,
Ikeda, Y., see Inoue, C. (215) 119 Yahara, O. and Kikuchi, K.
Ikeguchi, M., Touge, T., Nishiyama, Y., Takeuchi, H., Kuriyama, S. and Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan
Ohkawa, M. (214) 7
Effects of successive repetitive transcranial magnetic stimulation on Itoyama, Y., see Kato, H. (208) 9
motor performances and brain perfusion in idiopathic Parkinson’s Izumo, S., see Kiwaki, T. (206) 17
disease (209) 41 Izzi, F., see Tombini, M. (213) 83
Ilieva, H., Nagano, I., Murakami, T., Shiote, M., Shoji, M. and Abe, K.
Sustained induction of survival p-AKT and p-ERK signals after
transient hypoxia in mice spinal cord with G93A mutant human Jacobs, D.A., Fung, K.-M., Cook, N.M., Schalepfer, W.W., Goldberg, H.L.
SOD1 protein (215) 57 and Stecker, M.M.
Imada, H., see Kohshi, K. (209) 115 Complex partial status epilepticus associated with anti-Hu paraneo-
Imai, Y., see Kato, H. (208) 9 plastic syndrome (213) 77
Imamichi, Y., see Kobayashi, T. (207) 11 Jacobs, L.D., see Nguyen, L.T. (209) 93
Inaba, S., see Ochi, H. (206) 109 Jacobson, S., see Puccioni-Sohler, M. (207) 87
Inamasu, J., Nakamura, Y. and Ichikizaki, K. Jakubowska, T., see Lojkowska, W. (216) 119
Induced hypothermia in experimental traumatic spinal cord injury: an Jankovic, J., see Hou, J.-G. (206) 59
update (209) 55 Japp, G., see Petereit, H.F. (206) 209
Inglese, M., see Holtmannspétter, M. (206) 27 Jardim, L., see Gomes, I. (214) 21
Inoue, C., Ikeda, Y., Tanaka, M., Sakazume, Y. and Okamoto, K. Jarosz, H., see Lojkowska, W. (216) 119
A case of mixed connective tissue disease showing a lymphoid follicle Jedrzejczak, T., see Lojkowska, W. (216) 119
in muscle pathology (215) 119 Jeppesen, T.D., Schwartz, M., Hansen, K., Danielsen, E.R., Wibrand, F. and
Inoue, N., Kunishige, M., Yoshida, S., Oshima, Y., Ohnishi, Y., Kuroda, Y., Vissing, J.
Asano, A., Yoshino, H., Matsumoto, T. and Mitsui, T. Late onset of stroke-like episode associated with a 3256C—T point
Dissociation between titer of anti-ganglioside antibody and severity of mutation of mitochondrial DNA (214) 17
symptoms in a case of Guillain—Barré syndrome with treatment-related Jiang, G.-X., see Cheng, Q. (215) 63
fluctuation (210) 105 Johkura, K., Joki, H., Johmura, Y., Momoo, T. and Kuroiwa, Y.
Inoue, T., Takenoshita, M., Shibata, M., Nishimura, M., Sakaue, G., Combination of infarctions in the posterior inferior cerebellar artery and
Shibata, S.C. and Mashimo, T. anterior spinal artery territories (207) |
Long-lasting effect of transcutaneous electrical nerve stimulation on the Johkura, K., see Susuki, K. (211) 89
thermal hyperalgesia in the rat model of peripheral neuropathy Johmura, Y., see Johkura, K. (207) 1
(211) 43 Johnson, M.A., see Chinnery, P.F. (211) 63
Inoue, T., see Kishikawa, K. (213) 19 Johnson, R., see Petrov, T. (209) 31
198 Cumulative Author Index, Volumes 206-216 (2003)
Joki, H., see Johkura, K. (207) | Kim, J.-S., Han, S.-R., Chung, S.-W., Kim, B.-S., Lee, K.-S., Kim, Y.-L,
Jones, S.J. and Brusa, A. Yang, D.-W., Kim, K.-S. and Kim, J.-W.
Neurophysiological evidence for long-term repair of MS lesions: The apolipoprotein E ¢€4 haplotype is an important predictor for
implications for axon protection (206) 193 recurrence in ischemic cerebrovascular disease (206) 31
Jongen, P.J.H., see Petereit, H.F. (206) 209 Kim, J.-W., see Kim, J.-S. (206) 31
Juengling, F.D., see Kassubek, J. (212) 85 Kim, K.-S., see Kim, J.-S. (206) 31
Kim, M., see Kim, N.-H. (206) 65
Kachko, L., see Ifergane, G. (213) 11 Kim, N.-H., Kim, H.-J., Kim, M. and Lee, K.-W.
Kadoya, T., see Wada, M. (208) 67 A novel SOD1 gene mutation in a Korean family with amyotrophic
Kaji, M., see Sato, Y. (212) 55 lateral sclerosis (206) 65
Kajimoto, Y., see Miwa, H. (211) 85 Kim, S., see Cauraugh, J.H. (207) 25
Kalichi, E.M.N., see Birbeck, G.L. (209) 65 Kim, S.B., see Cauraugh, J.H. (215) 13
Kalita, J., see Misra, U.K. (208) 25 Kim, Y.-I., see Kim, J.-S. (206) 31
Kalita, J., Ranjan, P., Misra, U.K. and Das, B.K. Kimura, K., see Saito, K. (210) 95
Hemichorea: a rare presentation of tuberculoma (208) 109 Kimura, T., see Itoh, T. (214) 7
Kamouchi, M., see Kishikawa, K. (213) 19 Kira, J.-i., see Ochi, H. (206) 109
Kamoun, M., see Li, J. (215) 95 Kira, J.-i., see Arakawa, K. (207) 31
Kanai, M., see Numakura, C. (210) 61 Kira, J.-i., see Osoegawa, M. (209) 5
Kanbak, G., see Durmaz, R. (215) 87 Kira, J.-i., see Furuya, H. (209) 75
Kanno, M., Matsumoto, M., Togashi, H., Yoshioka, M. and Mano, Y. Kirov, R., see Moyanova, S. (212) 59
Effects of repetitive transcranial magnetic stimulation on behavioral and Kishikawa, K., Kamouchi, M., Okada, Y., Inoue, T., Ibayashi, S. and
neurochemical changes in rats during an elevated plus-maze test lida, M.
(211) 5 Effects of carotid endarterectomy on cerebral blood flow and neuro-
Kapaki, E., see Paraskevas, G.P. (215) 51 psychological test performance in patients with high-grade carotid
Karenberg, A., see Moog, F.P. (213) 15 stenosis (213) 19
Kasner, S.E., see Kolb, S.J. (216) 11 Kitagawa, M., see Tamura, I. (209) 19
Kassubek, J., Juengling, F.D., Els, T., Spreer, J., Herpers, M., Krause, T., Kitaichi, M., see Mizuno, T. (213) 67
Moser, E. and Liicking, C.H. Kiwaki, T., Umehara, F., Arimura, Y., Izumo, S., Arimura, K., Itoh, K. and
Activation of a residual cortical network during painful stimulation in Osame, M.
long-term postanoxic vegetative state: a '"O—HO PET study The clinical and pathological features of peripheral neuropathy
(212) 85 accompanied with HTLV-I associated myelopathy (206) 17
Kastrup, O., see Gerwig, M. (215) 75 Knight, R.S., see Green, A.J.E. (212) 69
Katayama, T., see Itoh, T. (214) 7 Kobayashi, K., Nakano, H., Hayashi, M., Shimazaki, M., Fukutani, Y.,
Katayama, Y., see Sakamaki, M. (209) 69 Sasaki, K., Sugimori, K. and Koshino, Y.
Kato, H., Araki, T., Imai, Y., Takahashi, A. and Itoyama, Y. Association of phosphorylation site of tau protein with neuronal
Protection of dopaminergic neurons with a novel astrocyte modulating apoptosis in Alzheimer’s disease (208) 17
agent (R)-(—)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse Kobayashi, T., Matsumine, H., Zhang, J., Imamichi, Y., Mizuno, Y. and
model of Parkinson’s disease (208) 9 Hattori, N.
Kato, N., Arai, K. and Hattori, T. Pseudo-autosomal dominant inheritance of PARK2: two families with
Study of the rostral midbrain atrophy in progressive supranuclear palsy parkin gene mutations (207) 11
(210) 57 Koch, H.C., see Seyfert, S. (206) 85
Kato, T., see Wada, M. (208) 67 Kochen, S., see Bendersky, M. (211) 75
Kato, T., see Ito, Y. (209) 105 Koeppen, A.H.
Katsuse, O., Iseki, E., Marui, W. and Kosaka, K. A brief history of brain iron research (207) 95
Developmental stages of cortical Lewy bodies and their relation to Kofler, M., Kronenberg, M.F., Brenneis, C., Felber, A. and Saltuari, L.
axonal transport blockage in brains of patients with dementia with Lewy Cutaneous silent periods in intramedullary spinal cord lesions (216) 67
bodies (211) 29 Koga, H., see Takashima, Y. (214) 37
Kawabe, K., see Tagawa, K. (211) 23 Koga, M., see Ogawara, K. (210) 41
Kawai, M., see Ogawa, M. (210) 53 Koga, M., see Odaka, M. (210) 99
Kawanami, T., see Wada, M. (208) 67 Koh, P.L., see Au, W.L. (209) 101
Kay, R., see Li, H. (207) 65 Kohriyama, T., see Ochi, K. (208) 43
Keir, G., see Rejdak, K. (208) 1 Kohshi, K., Imada, H., Nomoto, S., Yamaguchi, R., Abe, H. and
Kennedy, P.G.E., Grinfeld, E. and Esiri, M.M. Yamamoto, H.
Absence of detection of Varicella-Zoster virus DNA in temporal artery Successful treatment of radiation-induced brain necrosis by hyperbaric
biopsies obtained from patients with giant cell arteritis oxygen therapy (209) 115
(215) 27 Koizumi, K., see Hanyu, H. (209) 25
Kertesz, A. and Munoz, D.G. Kokubun, N., see Odaka, M. (211) 93
Primary progressive aphasia and Pick complex (206) 97 Kolb, S.J., Costello, F., Lee, A.G., White, M., Wong, S., Schwartz, E.D.,
Kihira, T., see Miwa, H. (211) 85 Messe, S.R., Ellenbogen, J., Kasner, S.E. and Galetta, S.L.
Kihira, T., see Morita, S. (216) 183 Distinguishing ischemic stroke from the stroke-like lesions of MELAS
Kijima, K., see Numakura, C. (210) 61 using apparent diffusion coefficient mapping (216) 11
Kikuchi, K., see Itoh, T. (214) 7 K6lmel, H.W., see Petereit, H.F. (206) 209
Kikuchi, $., see Tamura, I. (209) 19 Komatsu, K.-i., Fukutake, T. and Hattori, T.
Kikuchi, S., see Houzen, H. (211) 49 Fingertip photoplethysmography and migraine (216) 17
Kim, B.-S., see Kim, J.-S. (206) 31 Komoto, J., see Miwa, H. (211) 85
Kim, H.-J., see Kim, N.-H. (206) 65 Kondo, T., see Miwa, H. (211) 85
Cumulative Author Index, Volumes 206—216 (2003)
Kondo, T., see Morita, S. (216) 183 Lewis, R.A., see Shah, J.R. (208) 113
Kortenska, L., see Moyanova, S. (212) 59 LeWitt, P.A., see Lorenzl, S. (207) 71
Kosaka, K., see Katsuse, O. (211) 29 Li, H., Wong, K.S. and Kay, R.
Kosaka, K., see Horimoto, Y. (216) 105 Relationship between the Oxfordshire Community Stroke Project
Koshino, Y., see Kobayashi, K. (208) 17 classification and vascular abnormalities in patients with predominantly
Kotorii, S., see Santa, Y. (212) 79 intracranial atherosclerosis (207) 65
Kowa, H., see Nakaso, K. (207) 19 Li, J., Gran, B., Zhang, G.-X., Ventura, E.S., Siglienti, I., Rostami, A. and
Koyama, S., see Itoh, T. (214) 7 Kamoun, M.
Kramer, P.D., see Frohman, E.M. (210) 65 Differential expression and regulation of IL-23 and IL-12 subunits and
Krause, A., see Bryer, A. (216) 47 receptors in adult mouse microglia (215) 95
Krause, T., see Kassubek, J. (212) 85 Li, X., see Qin, W. (210) 35
Krishna, S., see Mancuso, M. (209) 61 Lim, M.S.F., see Au, W.L. (209) 101
Krivoshapkin, V.G., see Green, A.J.E. (212) 69 Lim, T.C.C., see Au, W.L. (209) 101
Kronenberg, M.F., see Kofler, M. (216) 67 Lin, J.-J., Yueh, K.-C., Chang, D.-C., Chang, C.-Y., Yeh, Y.-H. and
Kuhlmann, T., see Briick, W. (206) 181 Lin, S.-Z.
Kunishige, M., see Inoue, N. (210) 105 The homozygote 10-copy genotype of variable number tandem repeat
Kunkel, L.M., see B6nnemann, C.G. (206) 71 dopamine transporter gene may confer protection against Parkinson’s
Kuntzer, T., Dunand, M., Schorderet, D.F., Vallat, J.-Michel., Hahn, A.F. disease for male, but not to female patients (209) 87
and Bogousslavsky, J. Lin, S.-Z., see Lin, J.-J. (209) 87
Phenotypic expression of a Pro 87 to Leu mutation in the connexin 32 Liu, W., see Qin, W. (210) 35
gene in a large Swiss family with Charcot—Marie—Tooth neuropathy Liu, X.-y., see Zhuo, M. (216) 135
(207) 77 Lo, S.S., Hall, W.A., Cho, K.H., Orner, J., Lee, C.K. and Dusenbery, K.E.
Kunzmann, V., see Seyfert, S. (206) 85 Radiation dose response for supratentorial low-grade glioma—institu-
Kuo-Leblanc, V., see Salloway, S. (206) 115 tional experience and literature review (214) 43
Kupsky, W.J., see Petrov, T. (209) 31 Lo, Y.L., Leoh, T.H., Loh, L.M. and Tan, C.E.
Kurita, K., see Wada, M. (208) 67 Statin therapy and small fibre neuropathy: a serial electrophysiological
Kuriyama, S., see Ikeguchi, M. (209) 41 study (208) 105
Kuroda, Y., see Takashima, H. (207) 59 Locatelli, L., see Zivadinov, R. (210) 73
Kuroda, Y., see Inoue, N. (210) 105 Loh, L.M., see Lo, Y.L. (208) 105
Kuroda, Y., see Satoh, J.-i. (212) 11 Loh, N.K., see Au, W.L. (209) 101
Kuroda, Y., see Takashima, Y. (214) 37 Lojkowska, W., Ryglewicz, D., Jedrzejczak, T., Minc, S., Jakubowska, T.,
Kurohara, K., see Satoh, J.-1. (212) 11 Jarosz, H. and Bochynska, A.
Kuroiwa, Y., see Johkura, K. (207) 1 The effect of cholinesterase inhibitors on the regional blood flow in
Kuroiwa, Y., see Susuki, K. (211) 89 patients with Alzheimer’s disease and vascular dementia (216) 119
Kusumi, M., see Nakaso, K. (207) 19 Lopes, R., see Patti, F. (211) 55
Kuwabara, S., see Ogawara, K. (210) 41 Lopez, L., Cimadevilla, J.M., Aller, M.A., Arias, J., Nava, M.P. and
Kuwabara, S., see Odaka, M. (211) 93 Arias, J.L.
Kuwabara, S., see Ito, S. (216) 179 Diurnal locomotor activity and oxidative metabolism of the supra-
Kuwert, T., see Hilz, M.J. (216) 153 chiasmatic nucleus in two models of hepatic insufficiency (212) 93
Lorenzl, S., Albers, D.S., LeWitt, P.A., Chirichigno, J.W., Hilgenberg, S.L.,
Cudkowicz, M.E. and Beal, M.F.
Lahat, N., see Shapiro, S. (206) 43 Tissue inhibitors of matrix metalloproteinases are elevated in
Lai, E.C., see Trail, M. (209) 79 cerebrospinal fluid of neurodegenerative diseases (207) 71
Lam, W.W.M., see Mok, V.C.T. (216) 55 Lozano, R., see Barrachina, M. (215) 105
Larner, A.J., see Doran, M. (216) 127 Lu, C.-S., see Wong, K.S. (216) 81
Lassmann, H. Liicking, C.H., see Kassubek, J. (212) 85
Hypoxia-like tissue injury as a component of multiple sclerosis lesions Lukas, C., see Hoffmann, V. (211) 81
(206) 187 Lum, S.Y., see Tan, E.-K. (216) 163
Latov, N., see Chin, R.L. (210) 19 Lupi, M., see Rizzardini, M. (207) 51
Law, H.Y., see Wilder-Smith, E. (213) 25 Lycklama a Nijeholt, G. and Barkhof, F.
Lazeron, R.H.C., Rombouts, S.A.R.B., de Sonneville, L., Barkhof, F. and Differences between subgroups of MS: MRI findings and correlation
Scheltens, P. with histopathology (206) 173
A paced visual serial addition test for fMRI (213) 29
Leary, S.M. and Thompson, A.J.
Interferon beta-1a in primary progressive multiple sclerosis Macaskill, P., see Barnett, M.H. (213) 1
(206) 215 Madkour, O., see Elwan, O. (211) 15
Lee, A.G., see Kolb, S.J. (216) 11 Malcovati, L., see Appenzeller, O. (207) 37
Lee, C.K., see Lo, S.S. (214) 43 Manconi, M., see Govoni, V. (216) 99
Lee, K.-S., see Kim, J.-S. (206) 31 Mancuso, M., Filosto, M., Stevens, J.C., Patterson, M., Shanske, S.,
Lee, K.-W., see Kim, N.-H. (206) 65 Krishna, S. and DiMauro, S.
Leite, A.C.C., Mendonga, G.A.S., Serpa, M.J.A., Nascimento, O.J.M. and Mitochondrial myopathy and complex III deficiency in a patient
Araujo, Abelardo Q.-C. with a new stop-codon mutation (G339X) in the cytochrome b gene
Neurological manifestations in HTLV-I-infected blood donors (209) 61
(214) 49 Mandal, S.K., see Misra, U.K. (208) 25
Lenzi, C., see Annunziata, P. (213) 55 Manelfe, C., see Clanet, M. (206) 139
Leoh, T.H., see Lo, Y.L. (208) 105 Mangolini, A., see Rizzardini, M. (207) 51
Lerner, A., see Shapiro, S. (206) 43 Mano, Y., see Kanno, M. (211) 5
200 Cumulative Author Index, Volumes 206-216 (2003)
Mantegazza, R., Baggi, F., Bernasconi, P., Antozzi, C., Confalonieri, P., Misra, U.K., see Kalita, J. (208) 109
Novellino, L., Spinelli, L., Ferro, M.T., Beghi, E. and Cornelio, F. Mitoma, H., Ishida, K., Shizuka-Ikeda, M. and Mizusawa, H.
Video-assisted thoracoscopic extended thymectomy and extended Dual impairment of GABA,- and GABAg-receptor-mediated syn-
transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis aptic responses by autoantibodies to glutamic acid decarboxylase
patients: remission after 6 years of follow-up (212) 31 (208) 51
Marciani, M.G., see Tombini, M. (213) 83 Mitsui, T., see Inoue, N. (210) 105
Mareni, C., see Marini, V. (212) 75 Mittelhamm, F., see Hecht, M.J. (213) 47
Marin, J., see Servera, E. (209) 111 Miwa, H., Kajimoto, Y., Nakanishi, I., Morita, S., Komoto, J., Kihira, T.
Marini, V., Ferrera, L., Dorcaratto, A., Viale, G., Origone, P., Mareni, C. and Kondo, T.
and Garre, C. T2-low signal intensity in the cortex in multiple system atrophy (211)
Identification of a novel KR/T/ mutation in an Italian family with 85
cerebral cavernous malformation by the protein truncation test (212) 75 Miwa, H., see Morita, S. (216) 183
Markovic, M., Trajkovic, V., Drulovic, J., Mesaros, S., Stojsavljevic, N., Mizuno, T., Takanashi, Y., Onodera, H., Shigeta, M., Tanaka, N., Yuya, H.,
Dujmovic, I. and Stojkovic, M.M. Kitaichi, M. and Nakajima, K.
Antibodies against myelin oligodendrocyte glycoprotein in the A case of lymphomatoid granuiomatosis/angiocentric immunoprolifer-
cerebrospinal fluid of multiple sclerosis patients (211) 67 ative lesion with long clinical course and diffuse brain involvement
Marui, W., see Katsuse, O. $211) 29 (213) 67
Mashimo, T., see Inoue, T. (211) 43 Mizuno, Y., see Kobayashi, T. (207) 11
Mashimo, T., see Shibuta, S. (215) 31 Mizusawa, H., see Mitoma, H. (208) 51
Masters, C.L., see Green, A.J.E. (212) 69 Mochi, M., Cevoli, S., Cortelli, P., Pierangeli, G., Scapoli, C., Soriani, S.
Matsui, M., see Wang, H.-Y. (216) 61 and Montagna, P.
Matsuki, T., see Numakura, C. (210) 61 Investigation of an LDLR gene polymorphism (19p13.2) in suscepti-
Matsumine, H., see Kobayashi, T. (207) 11 bility to migraine without aura (213) 7
Matsumoto, H., see Houzen, H. (211) 49 Modrego, P.J. and Pina, M.A.
Matsumoto, M., see Kanno, M. (211) 5 Trends in prevalence and incidence of multiple sclerosis in Bajo
Matsumoto, M., see Horimoto, Y. (216) 105 Aragon, Spain (216) 89
Matsumoto, T., see Inoue, N. (210) 105 Mok, V., see Wong, K.S. (216) 81
Matsumoto, T., see Takashima, Y. (214) 37 Mok, V.C.T., Fan, Y.H., Lam, W.W.M., Hui, A.C.F. and Wong, K.S.
Matsumura, T., see Tagawa, K. (211) 23 Small subcortical infarct and intracranial large artery disease in Chinese
Matsushima, K., see Wang, H.-Y. (216) 61 (216) 55
Matsuyama, Z., Murase, M., Shimizu, H., Aoki, Y., Hayashi, M., Momoo, T., see Johkura, K. (207) 1
Hozumi, I. and Inuzuka, T. Montagna, P., see Mochi, M. (213) 7
A novel insertion mutation of acetazolamide-responsive episodic ataxia Monti, F., see Zivadinov, R. (210) 73
in a Japanese family (210) 91 Monti-Bragadin, L., see Zivadinov, R. (216) 113
Mayer, S.A., see Claassen, J. (211) 37 Moog, F.P. and Karenberg, A.
Mayer, T.O. and Biller, J. St. Francis came at dawn—the miraculous recovery of a hemiplegic
Antiplatelet prescribing patterns for TIA and ischemic stroke: the monk in the Middle Ages (213) 15
Indiana University experience (207) 5 Moore, P., see Halpern, C. (208) 31
McCombe, P., see Harness, J. (216) 33 Mori, E., see Ishii, K. (215) 71
McCombe, P.A., see Zhang, B. (212) 37 Mori, M., see Ogawara, K. (210) 41
McCombe, P.A., see Athanasas-Platsis, S. (214) 27 Mori, T., see Ishii, K. (215) 71
McDougall, A.J. and McLeod, J.G. Morishita, M., see Horimoto, Y. (216) 105
Autonomic nervous system function in multiple sclerosis (215) 79 Morita, S., see Miwa, H. (211) 85
McLeod, J.G., see Barnett, M.H. (213) 1 Morita, S., Miwa, H., Kihira, T. and Kondo, T.
McLeod, J.G., see McDougall, A.J. (215) 79 Cerebellar ataxia and leukoencephalopathy associated with cobalamin
MeMillan, C., see Halpern, C. (208) 31 deficiency (216) 183
McQuilty, R., see Pamphlett, R. (216) 95 Morita, Y., Osaki, Y., Doi, Y., Forghani, B. and Gilden, D.H.
Meisel, M., see Miiller, T. (213) 61 Chronic active VZV infection manifesting as zoster sine herpete, zoster
Mendongea, G.A.S., see Leite, A.C.C. (214) 49 paresis and myelopathy (212) 7
Mercon, M., see Puccioni-Sohler, M. (207) 87 Morton, H., see Zhang, B. (212) 37
Merkelbach, S., see Petereit, H.F. (206) 209 Morton, H., see Athanasas-Platsis, S. (214) 27
Mesaros, S., see Markovic, M. (211) 67 Morton, H., see Harness, J. (216) 33
Messé, S.R., see Kolb, S.J. (216) 11 Moser, A., Thiimen, A. and Qadri, F.
Metoki, N., see Sato, Y. (212) 55 Modulation of striatal serotonin and opioid receptor mRNA expression
Meyer, B.-U., see Gerwig, M. (215) 75 following systemic N-methyl-norsalsolinol administration (216) 109
Miles, T.S., see Charlton, C.S. (208) 79 Moser, E., see Kassubek, J. (212) 85
Miller, A., see Shapiro, S. (206) 43 Mostafa, M., see Elwan, O. (211) 15
Minami, M., see Ogata, A. (206) 79 Moyanova, S., Kirov, R. and Kortenska, L.
Mince, S., see Lojkowska, W. (216) 119 Multi-unit activity suppression and sensorimotor deficits after endothe-
Minematsu, K., see Saito, K. (210) 95 lin-1-induced middle cerebral artery occlusion in conscious rats (212)
Minko, T., see Appenzeller, O. (207) 37 59
Minohara, M., see Ochi, H. (206) 109 Mugnaini, F., see Annunziata, P. (213) 55
Minohara, M., see Osoegawa, M. (209) 5 Miller, T., see Hoffmann, V. (211) 81
Miro, O., see Casademont, J. (206) 23 Miiller, T., Meisel, M., Russ, H. and Przuntek, H.
Misra, U.K., Kalita, J., Pandey, S. and Mandal, S.K. Motor impairment influences Farnsworth-Munsell 100 Hue test error
Predictors of gastrointestinal bleeding in acute intracerebral haemor- scores in Parkinson’s disease patients (213) 61
rhage (208) 25 Munoz, D.G., see Kertesz, A. (206) 97
Cumulative Author Index, Volumes 206-216 (2003)
Murai, H., see Ochi, H. (206) 109 Ochi, H., see Osoegawa, M. (209) 5
Murai, H., see Osoegawa, M. (209) 5 Ochi, K., Kohriyama, T., Higaki, M., Ikeda, J., Harada, A. and
Murai, H., see Furuya, H. (209) 75 Nakamura, S.
Murakami, T., see Ilieva, H. (215) 57 Changes in serum macrophage-related factors in patients with chronic
Murase, M., see Matsuyama, Z. (210) 91 inflammatory demyelinating polyneuropathy caused by intravenous
Murray, J.D., see Swanson, K.R. (216) | immunoglobulin therapy (208) 43
Oda, S., see Ito, S. (216) 179
Odaka, M., Koga, M., Yuki, N., Susuki, K. and Hirata, K.
Nagano, I., see Ilieva, H. (215) 57 Longitudinal changes of anti-ganglioside antibodies before and after
Nagashima, K., see Ogata, A. (206) 79 Guillain-Barré syndrome onset subsequent to Campylobacter jejuni
Nagel, M. and Zangemeister, W.H. enteritis (210) 99
The effect of transcranial magnetic stimulation over the cerebellum Odaka, M., Yuki, N., Kokubun, N., Hirata, K. and Kuwabara, S.
on the synkinesis of coordinated eye and head movements (213) 35 Axonal Guillain-Barré syndrome associated with axonal Charcot
Nakajima, K., see Mizuno, T. (213) 67 Marie— Tooth disease (211) 93
Nakajima, M., see Saito, K. (210) 95 Ogata, A., Hamaue, N., Terado, M., Minami, M., Nagashima, K. and
Nakamura, S., see Ochi, K. (208) 43 Tashiro, K.
Nakamura, T., see Takashima, H. (207) 59 Isatin, an endogenous MAO inhibitor, improves bradykinesia and
Nakamura, Y., see Inamasu, J. (209) 55 dopamine levels in a rat model of Parkinson’s disease induced by
Nakanishi, I., see Miwa, H. (211) 85 Japanese encephalitis virus (206) 79
Nakano, H., see Kobayashi, K. (208) 17 Ogawa, M., Shigeto, H., Yamamoto, T., Oya, Y., Wada, K., Nishikawa, T.
Nakashima, K., see Nakaso, K. (207) 19 and Kawai, M.
Nakaso, K., Yasui, K., Kowa, H., Kusumi, M., Ueda, K., Yoshimoto, Y., D-Cycloserine for the treatment of ataxia in spinocerebellar degener-
Takeshima, T., Sasaki, K. and Nakashima, K. ation (210) 53
Hypertrophy of IMC of carotid artery in Parkinson’s disease is Ogawa, M., see Tagawa, K. (211) 23
associated with L-DOPA, homocysteine, and MTHFR genotype (207) Ogawara, K., Kuwabara, S., Koga, M., Mori, M., Yuki, N. and
19 Hattori, T.
Nakazawa, H., see Horimoto, Y. (216) 105 Anti-GMIb IgG antibody is associated with acute motor axonal
Nalini, A., see Gourie-Devi, M. (209) 13 neuropathy and Campylobacter jejuni infection (210) 41
Nascimento, O.J.M., see Leite, A.C.C. (214) 49 Ohkawa, M., see Ikeguchi, M. (209) 41
Nasuelli, D., see Zivadinov, R. (210) 73 Ohnishi, Y., see Inoue, N. (210) 105
Nasuelli, D., see Zivadinov, R. (216) 113 Ohyagi, Y., see Furuya, H. (209) 75
Nava, M.P., see Lopez, L. (212) 93 Okada, Y., see Hagiwara, N. (212) 99
Navarro, C., see Seijo-Martinez, M. (208) 87 Okada, Y., see Kishikawa, K. (213) 19
Nelson, N.D., see Trail, M. (209) 79 Okada, Y., see Irie, F. (215) 115
Neund@rfer, B., see Brown, C.M. (208) 71 Okamoto, K., see Inoue, C. (215) 119
Neundorfer, B., see Hecht, M.J. (213) 47 Oki, T., see Ito, S. (216) 179
Neund@rfer, B., see Hilz, M.J. (216) 153 Onai, N., see Wang, H.-Y. (216) 61
Newman, N.J., see Thambisetty, M. (208) 93 Ono, S., see Wada, M. (208) 67
Ng, I., see Wilder-Smith, E. (213) 25 Onodera, H., see Mizuno, T. (213) 67
Nguyen, K.B., see Zhang, B. (212) 37 Origone, P., see Marini, V. (212) 75
Nguyen, L.T., Ramanathan, M., Weinstock-Guttman, B., Baier, M., Orner, J., see Lo, S.S. (214) 43
Brownscheidle, C. and Jacobs, L.D. Osaki, Y., see Morita, Y. (212) 7
Sex differences in in vitro pro-inflammatory cytokine production from Osakovsky, V.L., see Green, A.J.E. (212) 69
peripheral blood of multiple sclerosis patients (209) 93 Osame, M., see Kiwaki, T. (206) 17
Niehaus, L., see Gerwig, M. (215) 75 Osame, M., see Umehara, F. (215) 111
Niino, M., see Houzen, H. (211) 49 Oshima, Y., see Inoue, N. (210) 105
Nishikawa, T., see Ogawa, M. (210) 53 Osoegawa, M., see Ochi, H. (206) 109
Nishimura, M., see Inoue, T. (211) 43 Osoegawa, M., Ochi, H., Minohara, M., Murai, H., Umehara, F.,
Nishino, I., see Tagawa, K. (211) 23 Furuya, H., Yamada, T. and Kira, J.-i.
Nishiyama, Y., see Ikeguchi, M. (209) 41 Myelitis with atopic diathesis: a nationwide survey of 79 cases in Japan
Nishiyama, Y., see Sakamaki, M. (209) 69 (209) 5
Nogoshi, S., see Houzen, H. (211) 49 O’Suilleabhain, P., see Frohman, E.M. (210) 65
Nomoto, S., see Kohshi, K. (209) 115 Otsuki, M., see Tamura, I. (209) 19
Nonaka, I., see Tagawa, K. (211) 23 Oya, Y., see Ogawa, M. (210) 53
Nora, D.B., see Gomes, I. (214) 21
Novellino, L., see Mantegazza, R. (212) 31
Numakura, C., Shirahata, E., Yamashita, S., Kanai, M., Kijima, K., Palace, J.
Matsuki, T. and Hayasaka, K. Clinical and laboratory characteristics of secondary progressive MS
Screening of the early growth response 2 gene in Japanese patients with (206) 131
Charcot—MariToeo—th disease type | (210) 61 Palau, F., see Seijo-Martinez, M. (208) 87
Nunes, R.G., see de Freitas, G.R. (210) 31 Palermo, F., see Patti, F. (211) 55
Pamphlett, R., Todd, E., Vink, R., McQuilty, R. and Cheema, S.S.
Magnesium supplementation does not delay disease onset or increase
Ochi, H., Murai, H., Osoegawa, M., Minohara, M., Inaba, S. and Kira, J.-1. survival in a mouse model of familial ALS (216) 95
Juvenile muscular atrophy of distal upper extremity associated with Pandey, S., see Misra, U.K. (208) 25
airway allergy: Two cases successfully treated by plasma exchange Paolillo, A., see Bellomi, F. (215) 3
(206) 109 Papageorgiou, C., see Paraskevas, G.P. (215) 51
202 Cumulative Author Index, Volumes 206—216 (2003)
Paraskevas, G.P., Kapaki, E., Petropoulou, O., Anagnostouli, M., Ranjan, P., see Kalita, J. (208) 109
Vagenas, V. and Papageorgiou, C. Rascol, O., see Vidal, R. (207) 110
Plasma levels of antioxidant vitamins C and E are decreased in vascular Rauschka, H., Retzl, J., Baumhackl, U., Bankl, H.C., Salomonowitz, E. and
parkinsonism (215) 51 Schmidbauer, M.
Parry, G.J., see Walk, D. (214) 3 Subacute brainstem angioencephalopathy: a case report and review of
Patel, H., see Wilkinson, P.A. (216) 43 the literature (208) 101
Patterson, M., see Mancuso, M. (209) 61 Reggio, A., see Patti, F. (211) 55
Patti, F., Cacopardo, M., Palermo, F., Ciancio, M.R., Lopes, R., Restivo, D. Regidor, I., see Cid, C. (206) 91
and Reggio, A. Reimann, J., see Bonnemann, C.G. (206) 71
Health-related quality of life and depression in an Italian sample of Rejdak, K., Petzold, A., Sharpe, M.A., Smith, M., Keir, G., Stelmasiak, Z.,
multiple sclerosis patients (211) 55 Thompson, E.J. and Giovannoni, G.
Pauli, E., see Hammen, (215) 21 Serum and urine nitrate and nitrite are not reliable indicators of
Pauli, E., see Hilz, M.J. (216) 153 intrathecal nitric oxide production in acute brain injury (208) 1
Pavanni, R., see Tan, E.-K. (216) 163 Restivo, D., see Patti, F. (211) 55
Peasley, M.A. and Shi, R. Retzl, J., see Rauschka, H. (208) 101
Ischemic insult exacerbates acrolein-induced conduction loss and Ridding, M.C., see Charlton, C.S. (208) 79
axonal membrane disruption in guinea pig spinal cord white matter Rios, M., see Puccioni-Sohler, M. (207) 87
(216) 23 Rizzardini, M., Lupi, M., Bernasconi, S., Mangolini, A. and Cantoni, L.
Pérez, D., see Servera, E. (209) 111 Mitochondrial dysfunction and death in motor neurons exposed to the
Petereit, H.F., Pukrop, R., Fazekas, F., Bamborschke, S.U., Répele, S.., glutathione-depleting agent ethacrynic acid (207) 51
K6lmel, H.W., Merkelbach, S., Japp, G., Jongen, P.J.H., Hartung, H.P. Rocca, M.A., see Holtmannspétter, M. (206) 27
and Hommes, O.R. Rocca, M.A., see Horsfield, M.A. (216) 169
Low interleukin-10 production is associated with higher disability and Rodnitzky, R.L., see Uc, E.Y. (212) 1
MRI lesion load in secondary progressive multiple sclerosis Rodriguez-Santiago, B., see Casademont, J. (206) 23
(206) 209 Rombouts, S.A.R.B., see Lazeron, R.H.C. (213) 29
Petropoulou, O., see Paraskevas, G.P. (215) 51 Ropele, S., see Petereit, H.F. (206) 209
Petrov, T., Rafols, J.A., Alousi, S.S., Kupsky, W.J., Johnson, R., Shah, J., Romigi, A., see Tombini, M. (213) 83
Shah, A. and Watson, C. Rosenberg, C., see Salloway, S. (206) 115
Cellular compartmentalization of phosphorylated elF2a and neuronal Rossi, P., see Horsfield, M.A. (216) 169
NOS in human temporal lobe epilepsy with hippocampal sclerosis (209) Rostami, A., see Li, J. (215) 95
31 Rovaris, M., see Holtmannspétter, M. (206) 27
Petzold, A., see Rejdak, K. (208) 1 Rovaris, M., see Horsfield, M.A. (216) 169
Pierangeli, G., see Mochi, M. (213) 7 Rugilo, C., see Bendersky, M. (211) 75
Pimenta, G., see Puccioni-Sohler, M. (207) 87 Russ, H., see Miiller, T. (213) 61
Pina, M.A., see Modrego, P.J. (216) 89 Ryglewicz, D., see Lojkowska, W. (216) 119
Pinto, F., see Irony-Tur-Sinai, M. (206) 49
Placidi, F., see Tombini, M. (213) 83 Sadanaga-Akiyoshi, F., see Takashima, Y. (214) 37
Platonov, F.A., see Green, A.J.E. (212) 69 Saida, T., see Wang, H.-Y. (216) 61
Platsch, G., see Hilz, M.J. (216) 153 Saito, K., Kimura, K., Minematsu, K., Shiraishi, A. and Nakajima, M.
Pohlau, D., see Hoffmann, V. (211) 81 Transient global amnesia associated with an acute infarction in the
Polman, C., see *t Hart, B.A. (212) 21 retrosplenium of the corpus callosum (210) 95
Poon, P.W.F., see Chiu, T.W. (216) 143 Sakakibara, R., see Ito, S. (216) 179
Pozharov, V., see Appenzeller, O. (207) 37 Sakamaki, M., Igarashi, H., Nishiyama, Y., Hagiwara, H., Ando, J.,
Pozzilli, C., see Bellomi, F. (215) 3 Chishiki, T., Curran, B.C. and Katayama, Y.
Pradeep Kumar, S., see Sylaja, P.N. (215) 9 Effect of glycerol on ischemic cerebral edema assessed by magnetic
Pruim, J., see Schaafsma, A. (210) 23 resonance imaging (209) 69
Przuntek, H., see Hoffmann, V. (211) 81 Sakaue, G., see Inoue, T. (211) 43
Przuntek, H., see Miiller, T. (213) 61 Sakazume, Y., see Inoue, C. (215) 119
Puccioni-Sohler, M., Chimelli, L., Merg on, M., Gong alves, R.R., Salinas, M., see Cid, C. (206) 91
Pimenta, G., Bianco, C., Rios, M. and Jacobson, S. Salloway, S., Gur, T., Berzin, T., Tavares, R., Zipser, B., Correia, S.,
Pathological and virological assessment of acute HTLV-I-associated Hovanesian, V., Fallon, J., Kuo-Leblanc, V., Glass, D., Hulette, C.,
myelopathy complicated with encephalopathy and systemic inflamma- Rosenberg, C., Vitek, M. and Stopa, E.
tion (207) 87 Corrigendum to “Effect of APOE genotype on microvascular basement
Pukrop, R., see Petereit, H.F. (206) 209 membrane in Alzheimer’s disease” [J. Neurol. Sci. 203-204 (2002)
Puli, S.R., see Bermel, R.A. (208) 57 183-187] (206) 115
Salomonowitz, E., see Rauschka, H. (208) 101
Saltuari, L., see Kofler, M. (216) 67
Qadri, F., see Moser, A. (216) 109 Sancho, J., see Servera, E. (209) 111
Qin, W., Zhang, T., Han, J., Tang, L., Li, X., Feng, G., Liu, W. and He, L. Sander, H.W., see Chin, R.L. (210) 19
A novel insertion mutation in spastin gene is the cause of spastic Sankara Sarma, P., see Sylaja, P.N. (215) 9
paraplegia in a Chinese family (210) 35 Santa, Y., Uyama, E., Chui, D.H., Arima, M., Kotorii, S., Takahashi, K. and
Tabira, T.
Genetic, clinical and pathological studies of CADASIL in Japan: a
Radhakrishnan, K., see Sylaja, P.N. (215) 9 partial contribution of Notch3 mutations and implications of smooth
Rafols, J.A., see Petrov, T. (209) 31 muscle cell degeneration for the pathogenesis (212) 79
Ramanathan, M., see Nguyen, L.T. (209) 93 Sasaki, K., see Nakaso, K. (207) 19
Ramesar, R., see Bryer, A. (216) 47 Sasaki, K., see Kobayashi, K. (208) 17